EUVIMEDEUVIMED entdecken
Crossref

Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague–Dawley Rats: Targeting HMGB-1/NF-κB Pathway

Prachi Mistry, Sanjiv Prajapati, Paridhi Vadher, Jhanvi Soni, Vijay Kevlani iD

ASSAY and Drug Development Technologies · 2026

DOI: 10.1089/adt.2025.057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2026. Verfasst von Prachi Mistry und 4 weiteren Autor:innen. Beteiligte Einrichtung: L.J. Institute of Pharmacy, L J University, Ahmedabad, India. Hauptthemen laut MEDLINE: Reperfusion Injury, NF-kappa B, Neuroprotective Agents, HMGB1 Protein. Die Arbeit nennt 74 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stroke is an intricate oxidative and inflammatory response resulting from cerebral ischemia followed by reperfusion injury. Complex pathophysiology of stroke poses challenges for treatment. Peroxisome proliferator-activated receptor (PPAR) expression in the rat hippocampus is markedly elevated post cerebral ischemia/reperfusion (I/R) injury. Hence, saroglitazar, a dual PPAR-α/γ agonist, was investigated against cerebral I/R injury in rats. Male Sprague–Dawley rats were subjected to bilateral common carotid artery occlusion for 30 min and reperfusion for 3 days. During the reperfusion, animals were treated with vehicle or saroglitazar once a day for 3 days. The behavioral parameters were assessed, and animals were sacrificed to measure oxidative markers (malondialdehyde, superoxide dismutase, catalase, and reduced glutathione), inflammatory markers (interleukin-6, tumor necrosis factor-α, nuclear factor kappa-light chain enhancer of activated B cells (NF-κB), and high mobility group box 1 (HMGB-1) protein, infarction, and histopathology changes. Following I/R injury, antioxidant enzymes were reduced, while nitric oxide and inflammatory markers were increased in the disease group. In the rat hippocampus, these changes led to neurobehavioral impairment and cerebral infarction. Saroglitazar improved the levels of antioxidants and reduced inflammation; 2,3,5-triphenyltetrazolium chloride stain and histopathological analysis revealed the neuroprotective effect of saroglitazar in the hippocampus region. The neuroprotective effects of saroglitazar were attributed to its activation of both PPAR-α and PPAR-γ. It improved antioxidant levels and inhibited proinflammatory cytokines by suppressing the HMGB-1/NF-κB signaling pathway. These findings underscore the potential of saroglitazar in mitigating cerebral I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryNF-kappa BNeuroprotective AgentsHMGB1 ProteinBrain IschemiaPhenylpropionatesPyrrolesAnimalsRats, Sprague-DawleyMaleRatsSignal Transduction

Stichwörter der Autor:innen

HMGB-1NF-κBantioxidantsischemia/reperfusion injurysaroglitazarstroke

Substanzen

NF-kappa BNeuroprotective AgentsHMGB1 ProteinPhenylpropionatessaroglitazarPyrrolesHbp1 protein, rat

Autor:innen und Institutionen

  • L.J. Institute of Pharmacy, L J University, Ahmedabad, India.
  • Department of Pharmacology, Parul Institute of Pharmacy, Parul University, Waghodia, India.
  • School of Pharmacy, National Forensic Sciences University, Gandhinagar, India.

ORCID-Profile: Vijay Kevlani

Zitieren

APA

Mistry, P., Prajapati, S., Vadher, P., Soni, J., & Kevlani, V. (2026). Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague–Dawley Rats: Targeting HMGB-1/NF-κB Pathway. ASSAY and Drug Development Technologies. https://doi.org/10.1089/adt.2025.057

Vancouver

Mistry P, Prajapati S, Vadher P, Soni J, Kevlani V. Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague–Dawley Rats: Targeting HMGB-1/NF-κB Pathway. ASSAY and Drug Development Technologies. 2026. doi:10.1089/adt.2025.057

BibTeX
@article{Mistry2026,
  author = {Mistry, Prachi and Prajapati, Sanjiv and Vadher, Paridhi and Soni, Jhanvi and Kevlani, Vijay},
  title = {Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague–Dawley Rats: Targeting HMGB-1/NF-κB Pathway},
  journal = {ASSAY and Drug Development Technologies},
  year = {2026},
  doi = {10.1089/adt.2025.057}
}
Kostenlos starten →